糖尿病性神経障害の世界市場:疾患の種類別(自律神経障害、末梢神経障害、近位筋優位遺伝性運動感覚ニューロパチー、限局性神経障害)、治療別(薬物、理学療法、放射線療法、その他)、流通経路別(診療所、病院、薬局)、地域別予測

◆英語タイトル:Global diabetic neuropathy market Size study, by Disorder Type (autonomic Neuropathy, peripheral Neuropathy, proximal neuropathy and focal Neuropathy) Treatment (drugs, physiotherapy, radiotherapy and others) Distribution Channel (clinics, hospitals and pharmacy) and Regional Forecasts 2018-2025
◆商品コード:BZW9MR024
◆発行会社(リサーチ会社):Bizwit Research & Consulting
◆発行日:2019年3月7日
◆ページ数:約150
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル、日本、アメリカ、カナダ、イギリス、ドイツ、フランス、中国、インド、ブラジル、メキシコ
◆販売価格オプション(消費税別)
Single User(1名様閲覧用、印刷不可)USD3,950 ⇒換算¥434,500見積依頼/購入/質問フォーム
Corporate User(同一法人内共有可)USD5,550 ⇒換算¥610,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はBizwit Research & Consulting社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
Bizwit Research & Consulting社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

本資料は、糖尿病性神経障害の世界市場について調べ、糖尿病性神経障害の世界規模、市場動向、市場環境、疾患の種類別(自律神経障害、末梢神経障害、近位筋優位遺伝性運動感覚ニューロパチー、限局性神経障害)分析、治療別(薬物、理学療法、放射線療法、その他)分析、流通経路別(診療所、病院、薬局)分析、アメリカ市場規模、ヨーロッパ市場規模、アジア市場規模、日本市場規模、中国市場規模、関連企業情報などをまとめた調査レポートです。業界の主要なプレイヤーはPfizer Inc.、 Janssen Pharmaceuticals, Inc.、 Eli Lilly and Company、 Cephalon, Inc.、 ACTAVIS、 GlaxoSmithKline、MEDA Pharma GmbH & Co. KG 、 NeuroMetrix, Inc 、 Abbott Laboratories、Lupin Limitedなどです。
・イントロダクション
・エグゼクティブサマリー
・糖尿病性神経障害の世界市場概要
・糖尿病性神経障害の世界市場環境
・糖尿病性神経障害の世界市場動向
・糖尿病性神経障害の世界市場規模
・糖尿病性神経障害の世界市場規模:疾患の種類別(自律神経障害、末梢神経障害、近位筋優位遺伝性運動感覚ニューロパチー、限局性神経障害)
・糖尿病性神経障害の世界市場規模:治療別(薬物、理学療法、放射線療法、その他)
・糖尿病性神経障害の世界市場規模:流通経路別(診療所、病院、薬局)
・糖尿病性神経障害の世界市場:地域別市場規模・分析
・糖尿病性神経障害の北米市場規模・予測
・糖尿病性神経障害のアメリカ市場規模・予測
・糖尿病性神経障害のヨーロッパ市場規模・予測
・糖尿病性神経障害のアジア市場規模・予測
・糖尿病性神経障害の日本市場規模・予測
・糖尿病性神経障害の中国市場規模・予測
・関連企業情報
【レポートの概要】

Global diabetic neuropathy market to reach USD 5.8 billion by 2025.

Global diabetic neuropathy market is valued approximately USD 3.8 billion in 2017 and is anticipated to grow with a healthy growth rate of more than 5.4 % over the forecast period 2018-2025. Key trends in the market is advent of new therapeutics for treatment of neuropathy and favorable reimbursement scenario which is expected to foster the growth of the diabetic neuropathy market. For instance: In 2016 as per the University of Cambridge, researchers have led to the development of a new approach to treatment of neuropathic pain. Further, the project focuses on a novel way of indirectly modulating the effect of the TRPV1, a significant initiator of the sensation of pain. Additionally, the team worked to show the effectiveness of using certain peptides to interface with the function of TRPV1 with an aim to eliminate neuropathic pain. As a result, healthcare institutions would be capable to deliver new therapeutics for treatment of neuropathy.
Key driving factors for the diabetic neuropathy market are rising prevalence of diabetes coupled with the changing lifestyles that results in to unhealthy dietary habits and patterns. According the Health Metrics – American Heart Association, in 2010 the prevalence of diabetes for adults was recorded to be 6.4% globally. This is expected to increase and reach up to 7.7% by the end of 2030, across the globe. Similarly, as per the MRC United Kingdom 2015, the estimated diabetes prevalence for adults between age group of 20-79 worldwide was around 387 million in 2014 which is estimated to reach around 592 million people by 2023. As a result, people suffering from diabetes are prone to nerve damages which are expected to boost the growth of the diabetic neuropathy market during 2018-2025. Furthermore, rise in demand for better neuropathy drugs offer lucrative growth prospects for the diabetic neuropathy market across the globe. However, high cost associated with diabetic neuropathy along with the side effects of the drugs are expected to hinder the growth of the market during the forecast period.

On the basis of segmentation, the diabetic neuropathy market is segmented into disorder type, treatment and distribution channel. The disorder type segment of global Diabetic neuropathy market is classified into autonomic Neuropathy, peripheral neuropathy, proximal neuropathy and focal neuropathy of which proximal neuropathy dominates the market as it is the most commonly found disorder in type 2 diabetes. On the basis of treatment segment, the market is classified into drugs, physiotherapy, radiotherapy and others. The distribution channel segment is classified into clinics, hospitals and pharmacy.

The regional analysis of diabetic neuropathy market is considered for the key regions such as North America, Europe, Asia Pacific, Latin America and ROW. North America holds the leading position in diabetic neuropathy market owing to the increase in prevalence of diabetes, improved healthcare infrastructure along with the rise in research and development activities. Whereas, Asia-Pacific is expected to emerge as the fastest growing region in terms of market share. The growth of Asia-Pacific is witnessed owing to increase R&D activities for drug discovery along with increasing aging population. Also, improving healthcare infrastructure and services in rural areas is also expected to supplement the growth of Asia-Pacific over the forecast period.
The leading market players include-

 Pfizer Inc.
 Janssen Pharmaceuticals, Inc.
 Eli Lilly and Company
 Cephalon, Inc.
 ACTAVIS
 GlaxoSmithKline
 MEDA Pharma GmbH & Co. KG
 NeuroMetrix, Inc
 Abbott Laboratories
 Lupin Limited

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Disorder Type
 Autonomic Neuropathy
 Peripheral Neuropathy
 Proximal Neuropathy
 Focal Neuropathy
By Treatment:
 Drugs
 Physiotherapy
 Radiotherapy
 Others
By Distribution Channel:
 Clinics
 Hospitals
 Pharmacy
By Regions:
 North America
o U.S.
o Canada
 Europe
o UK
o Germany
o ROE
 Asia Pacific
o China
o India
o Japan
o ROAPEC
 LAMEA
o Brazil
o Mexico
 ROW
o Middle East & Africa

Furthermore, years considered for the study are as follows:

Historical year – 2015, 2016
Base year – 2017
Forecast period – 2018 to 2025

Target Audience of the Global Diabetic neuropathy Market in Market Study:

 Key Consulting Companies & Advisors
 Large, medium-sized, and small enterprises
 Venture capitalists
 Value-Added Resellers (VARs)
 Third-party knowledge providers
 Investment bankers
 Investors

【レポートの目次】

TABLE OF CONTENTS
Chapter 1. Global Diabetic Neuropathy Market Definition and Scope
1.1. Research Objective
1.2. Market Definition
1.3. Scope of The Study
1.4. Years Considered for The Study
1.5. Currency Conversion Rates
1.6. Report Limitation
Chapter 2. Research Methodology
2.1. Research Process
2.1.1. Data Mining
2.1.2. Analysis
2.1.3. Market Estimation
2.1.4. Validation
2.1.5. Publishing
2.2. Research Assumption
Chapter 3. Executive Summary
3.1. Global & Segmental Market Estimates & Forecasts, 2015-2025 (USD Billion)
3.2. Key Trends
Chapter 4. Global Diabetic Neuropathy Market Dynamics
4.1. Growth Prospects
4.1.1. Drivers
4.1.2. Restraints
4.1.3. Opportunities
4.2. Industry Analysis
4.2.1. Porter’s 5 Force Model
4.2.2. PEST Analysis
4.2.3. Value Chain Analysis
4.3. Analyst Recommendation & Conclusion
Chapter 5. Global Diabetic Neuropathy Market, By Disorder Type
5.1. Market Snapshot
5.2. Market Performance – Potential Model
5.3. Global Diabetic Neuropathy Market, Sub Segment Analysis
5.3.1. Autonomic Neuropathy
5.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.2. Peripheral Neuropathy
5.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.3. Proximal Neuropathy
5.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
5.3.4. Focal Neuropathy
5.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
5.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 6. Global Diabetic Neuropathy Market, By Treatment
6.1. Market Snapshot
6.2. Market Performance – Potential Model
6.3. Global Diabetic Neuropathy Market, Sub Segment Analysis
6.3.1. Drugs
6.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.2. Physiotherapy
6.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.3. Radiotherapy
6.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
6.3.4. Others
6.3.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
6.3.4.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 7. Global Diabetic Neuropathy Market, By Distribution Channel
7.1. Market Snapshot
7.2. Market Performance – Potential Model
7.3. Global Diabetic Neuropathy Market, Sub Segment Analysis
7.3.1. Clinics
7.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.1.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.2. Hospitals
7.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.2.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
7.3.3. Pharmacy
7.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
7.3.3.2. Regional breakdown estimates & forecasts, 2015-2025 (USD Billion)
Chapter 8. Global Diabetic Neuropathy Market, by Regional Analysis
8.1. Diabetic Neuropathy Market, Regional Market Snapshot (2015-2025)
8.2. North America Diabetic neuropathy Market Snapshot
8.2.1. U.S.
8.2.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.2. Disorder Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.3. Treatment breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.1.4. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2. Canada
8.2.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.2. Disorder Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.3. Treatment breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.2.2.4. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3. Europe Diabetic Neuropathy Market Snapshot
8.3.1. U.K.
8.3.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.2. Disorder Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.3. Treatment breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.1.4. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.3.2. Germany
8.3.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.2. Disorder Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.3. Treatment breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.2.4. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3. Rest of Europe
8.3.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.2. Disorder Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.3. Treatment breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.3.3.4. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4. Asia Diabetic Neuropathy Market Snapshot
8.4.1. China
8.4.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.2. Disorder Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.3. Treatment breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.1.4. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2. India
8.4.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.2. Disorder Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.3. Treatment breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.2.4. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3. Japan
8.4.3.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.2. Disorder Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.3. Treatment breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.3.4. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4. Rest of Asia Pacific
8.4.4.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.2. Disorder Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.3. Treatment breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.4.4.4. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5. Latin America Diabetic Neuropathy Market Snapshot
8.5.1. Brazil
8.5.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.2. Disorder Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.3. Treatment breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.1.4. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)

8.5.2. Mexico
8.5.2.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.2. Disorder Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.3. Treatment breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.5.2.4. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6. Rest of The World
8.6.1. Middle East and Africa
8.6.1.1. Market estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.2. Disorder Type breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.3. Treatment breakdown estimates & forecasts, 2015-2025 (USD Billion)
8.6.1.4. Distribution Channel breakdown estimates & forecasts, 2015-2025 (USD Billion)

Chapter 9. Competitive Intelligence
9.1. Company Market Share (Subject to Data Availability)
9.2. Top Market Strategies
9.3. Company Profiles
9.3.1. Pfizer Inc.
9.3.1.1. Overview
9.3.1.2. Financial (Subject to Data Availability)
9.3.1.3. Product Summary
9.3.1.4. Recent Developments
9.3.2. Janssen Pharmaceuticals, Inc.
9.3.3. Eli Lilly and Company
9.3.4. Cephalon, Inc.
9.3.5. ACTAVIS
9.3.6. GlaxoSmithKline
9.3.7. MEDA Pharma GmbH & Co. KG
9.3.8. NeuroMetrix, Inc
9.3.9. Abbott Laboratories
9.3.10. Lupin Limited

TABLE 1. LIST OF SECONDARY SOURCES, USED IN THE STUDY OF GLOBAL DIABETIC NEUROPATHY MARKET
TABLE 2. LIST OF PRIMARY SOURCES, USED IN THE STUDY OF GLOBAL DIABETIC NEUROPATHY MARKET
TABLE 3. GLOBAL DIABETIC NEUROPATHY MARKET, REPORT SCOPE
TABLE 4. YEARS CONSIDERED FOR THE STUDY
TABLE 5. EXCHANGE RATES CONSIDERED
TABLE 6. GLOBAL DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY REGION 2015-2025 (USD BILLION)
TABLE 7. GLOBAL DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY DISORDER TYPE 2015-2025 (USD BILLION)
TABLE 8. GLOBAL DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY TREATMENT 2015-2025 (USD BILLION)
TABLE 9. GLOBAL DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY DISTRIBUTION CHANNEL 2015-2025 (USD BILLION)
TABLE 10. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 11. GLOBAL DIABETIC NEUROPATHY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 12. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 13. GLOBAL DIABETIC NEUROPATHY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 14. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 15. GLOBAL DIABETIC NEUROPATHY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 16. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 17. GLOBAL DIABETIC NEUROPATHY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 18. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 19. GLOBAL DIABETIC NEUROPATHY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 20. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 21. GLOBAL DIABETIC NEUROPATHY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 22. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 23. GLOBAL DIABETIC NEUROPATHY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 24. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 25. GLOBAL DIABETIC NEUROPATHY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 26. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 27. GLOBAL DIABETIC NEUROPATHY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 28. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 29. GLOBAL DIABETIC NEUROPATHY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 30. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 31. GLOBAL DIABETIC NEUROPATHY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 32. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 33. GLOBAL DIABETIC NEUROPATHY MARKET BY REGION, ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 34. U.S. DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 35. U.S DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 36. U.S DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 37. U.S DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 38. CANADA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 39. CANADA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 40. CANADA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 41. CANADA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 42. UK DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 43. UK DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 44. UK DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 45. UK DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 46. GERMANY DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 47. GERMANY DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 48. GERMANY DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 49. GERMANY DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 50. ROE DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 51. ROE DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 52. ROE DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 53. ROE DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 54. CHINA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 55. CHINA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 56. CHINA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 57. CHINA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 58. INDIA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 59. INDIA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 60. INDIA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 61. INDIA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 62. JAPAN DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 63. JAPAN DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 64. JAPAN DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 65. JAPAN DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 66. ROAPAC DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 67. ROAPAC DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 68. ROAPAC DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 69. BRAZIL DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 70. BRAZIL DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 71. BRAZIL DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 72. BRAZIL DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 73. MEXICO DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 74. MEXICO DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 75. MEXICO DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 76. MEXICO DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 77. MIDDLE EAST & AFRICA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS, 2015-2025 (USD BILLION)
TABLE 78. MIDDLE EAST & AFRICA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 79. MIDDLE EAST & AFRICA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)
TABLE 80. MIDDLE EAST & AFRICA DIABETIC NEUROPATHY MARKET ESTIMATES & FORECASTS BY SEGMENT 2015-2025 (USD BILLION)

FIG 1. GLOBAL DIABETIC NEUROPATHY MARKET, RESEARCH METHODOLOGY
FIG 2. GLOBAL DIABETIC NEUROPATHY MARKET, MARKET ESTIMATION TECHNIQUES
FIG 3. GLOBAL MARKET SIZE ESTIMATES & FORECAST METHODS
FIG 4. GLOBAL DIABETIC NEUROPATHY MARKET, KEY TRENDS 2016
FIG 5. GLOBAL HEAT EXCHANGERS, GROWTH PROSPECTS 2017-2025
FIG 6. GLOBAL DIABETIC NEUROPATHY MARKET, PORTERS 5 FORCE MODEL
FIG 7. GLOBAL DIABETIC NEUROPATHY MARKET, PEST ANALYSIS
FIG 8. GLOBAL DIABETIC NEUROPATHY MARKET, VALUE CHAIN ANALYSIS
FIG 9. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 10. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 11. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 12. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 13. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 14. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 15. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 16. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 17. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 18. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 19. GLOBAL DIABETIC NEUROPATHY MARKET BY SEGMENT, 2015 & 2025 (USD BILLION)
FIG 20. GLOBAL DIABETIC NEUROPATHY MARKET, REGIONAL SNAPSHOT 2015 & 2025
FIG 21. NORTH AMERICA DIABETIC NEUROPATHY MARKET 2015 & 2025 (USD BILLION)
FIG 22. EUROPE DIABETIC NEUROPATHY MARKET 2015 & 2025 (USD BILLION)
FIG 23. ASIA PACIFIC DIABETIC NEUROPATHY MARKET 2015 & 2025 (USD BILLION)
FIG 24. LATIN AMERICA DIABETIC NEUROPATHY MARKET 2015 & 2025 (USD BILLION)
FIG 25. ROW DIABETIC NEUROPATHY MARKET 2015 & 2025 (USD BILLION)
FIG 26. GLOBAL DIABETIC NEUROPATHY MARKET, COMPANY MARKET SHARE ANALYSIS (2016)

【掲載企業】

Pfizer Inc.、 Janssen Pharmaceuticals, Inc.、 Eli Lilly and Company、 Cephalon, Inc.、 ACTAVIS、 GlaxoSmithKline、MEDA Pharma GmbH & Co. KG 、 NeuroMetrix, Inc 、 Abbott Laboratories、Lupin Limited

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[糖尿病性神経障害の世界市場:疾患の種類別(自律神経障害、末梢神経障害、近位筋優位遺伝性運動感覚ニューロパチー、限局性神経障害)、治療別(薬物、理学療法、放射線療法、その他)、流通経路別(診療所、病院、薬局)、地域別予測]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆